公开(公告)号：US20200368532A1

公开(公告)日：2020-11-26

申请号：US16985955

申请日：2020-08-05

Applicant: Medtronic, Inc.

Inventor： Gary W. King ,  Steven M. Goetz ,  Andrew H. Houchins ,  Jeffrey T. Keacher ,  Jordan J. Greenberg ,  Kenneth T. Heruth ,  Mark S. Lent ,  Paul W. Wacnik

IPC: A61N1/36

Abstract: Peripheral nerve field stimulation (PNFS) may be controlled based on detected physiological effects of the PNFS, which may be an efferent response to the PNFS. In some examples, a closed-loop therapy system may include a sensing module that senses a physiological parameter of the patient, which may be indicative of the patient's response to the PNFS. Based on a signal generated by the sensing module, the PNFS may be activated, deactivated or modified. Example physiological parameters of the patient include heart rate, respiratory rate, electrodermal activity, muscle activity, blood flow rate, sweat gland activity, pilomotor reflex, or thermal activity of the patient's body. In some examples, a patient pain state may be detected based on a signal generated by the sensing module, and therapy may be controlled based on the detection of the pain state.

公开(公告)号：US10806344B2

公开(公告)日：2020-10-20

申请号：US14137673

申请日：2013-12-20

Applicant: Medtronic, Inc.

Inventor： Steven M. Goetz

IPC: A61B5/00 ,  A61N1/372 ,  A61M5/172 ,  A61N1/36

Abstract: Techniques for remotely titrating a therapy delivered using an implantable medical device system are disclosed. An implantable medical device delivers therapy according to a first program. The system collects patient data relating to at least one of an efficacy of, or side effects resulting from, the delivered therapy, and transmits the patient data to a remote network device. A clinician may then analyze the patient data and determine if changes to the therapy are warranted. The clinician may then transmit a programming change, e.g., a modification to the first program or a new, second program, to the implantable medical device system, and the implantable medical device may deliver therapy according to the changed programming. The process of receiving patient data and modifying the therapy programming may be repeated multiple times until the therapy is adequately titrated, e.g., until the patient data indicates adequate efficacy and/or acceptable side effects.

公开(公告)号：US20200171298A1

公开(公告)日：2020-06-04

申请号：US16786756

申请日：2020-02-10

Applicant: Medtronic, Inc.

Inventor： Steven M. Goetz ,  Richard T. Stone ,  Warren W. Ball ,  Carl D. Wahlstrand ,  Michael T. Hegland ,  Gabriela C. Molnar ,  James M. Olsen

IPC: A61N1/05 ,  A61N1/36 ,  A61N1/372

Abstract: The disclosure is directed to programming implantable stimulators to deliver stimulation energy via one or more implantable leads having complex electrode array geometries. The disclosure also contemplates guided programming to select electrode combinations and parameter values to support efficacy. The techniques may be applied to a programming interface associated with a clinician programmer, a patient programmer, or both. A user interface permits a user to view electrodes from different perspectives relative to the lead. For example, the user interface provides a side view of a lead and a cross-sectional view of the lead. The user interface may include an axial control medium to select and/or view electrodes at different axial positions along the length of a lead, and a rotational control medium to select and/or view electrodes at different angular positions around a circumference of the lead.

公开(公告)号：US10535427B2

公开(公告)日：2020-01-14

申请号：US15866718

申请日：2018-01-10

Applicant: Medtronic, Inc.

Inventor： Steven M. Goetz

IPC: G06T15/00 ,  G16H30/40 ,  A61B6/00 ,  A61B6/03 ,  G06T19/00 ,  A61B34/10

Abstract: Devices, systems, and methods pertain to planning and providing guidance for a cranial based implantation of an implantable medical device or devices. The collection of data, such as data pertaining to the skull of the patient, the scalp of the patient, the vascular structure or neurological structures in the head of the patient, is performed. The data may be in the form of images, such as images generated by X-ray, magnetic resonance imaging, CT-scan and fluoroscopy. A surgeon can use the collected data to determine, for example, whether the patient is a candidate for a cranial implantation, whether the patient's skull and scalp can support the implantation, what configuration of device should be implanted, where the device should be implanted, and how the surgical incisions should be made.

公开(公告)号：US10441801B2

公开(公告)日：2019-10-15

申请号：US15601741

申请日：2017-05-22

Applicant: Medtronic, Inc.

Inventor： Steven M. Goetz

IPC: A61N1/37 ,  A61N1/372 ,  A61N1/08 ,  A61N1/36

Abstract: A programming-device user interface may include multiple levels of abstraction for programming treatment settings. A stimulation zone-programming interface may be at a highest level of abstraction and may include idealized stimulation zones. A field strength-programming interface may be at a middle level of abstraction and may include electromagnetic field-strength patterns generated by the stimulation zones, and/or electrode settings, and a depiction of how the electromagnetic fields interact with each other. An electrode-programming interface may be at a lowest level of abstraction and may depict treatment settings at an electrodes-view level. These interfaces may include a display of a stimulatable area of the patient's body. The display may include a depiction of leads and/or the underlying physiology, such as a depiction of a portion of a spine. Algorithms map treatment settings from one level of abstraction to settings at one or more other levels of abstraction.

公开(公告)号：US20180125388A1

公开(公告)日：2018-05-10

申请号：US15867262

申请日：2018-01-10

Applicant: Medtronic, Inc.

Inventor： James M. Olsen ,  Steven M. Goetz

IPC: A61B5/055 ,  A61N1/372 ,  A61B5/00 ,  A61N1/362

CPC classification number: A61B5/055 ,  A61B5/7203 ,  A61N1/362 ,  A61N1/37235 ,  A61N1/37247

Abstract: Changes in electrical stimulation therapy delivered via a medical device are coordinated with Functional Magnetic Resonance Imaging (fMRI) scans. In one example, a medical device delivers electrical stimulation therapy to a patient in an MRI unit, where the medical device is configured to cycle electrical stimulation therapy between a plurality of stimulation states. An indication that the medical device will cycle the electrical stimulation therapy or has cycled the electrical stimulation therapy while the patient is in the MRI unit or being imaged by the MRI unit is generated, and an MRI scan of the patient via an MRI workstation is initiated based on the indication. In another example, a medical device detects activation of an MRI scan and automatically switches stimulation states based upon the detection of the MRI scan, such that the scan is associated with a particular stimulation state.

公开(公告)号：US20180036530A1

公开(公告)日：2018-02-08

申请号：US15782272

申请日：2017-10-12

Applicant: Medtronic, Inc.

Inventor： Martin T. Gerber ,  Steven M. Goetz ,  Christopher Poletto

IPC: A61N1/36

CPC classification number: A61N1/36 ,  A61N1/36057 ,  A61N1/36075 ,  A61N1/36082 ,  A61N1/36132

Abstract: Prophylactic stimulation and abortive electrical stimulation are delivered to a cranial nerve, including, e.g. an occipital or trigeminal nerve to treat symptoms of various conditions, including, e.g. occipital neuralgia or migraines.

公开(公告)号：US20180008820A1

公开(公告)日：2018-01-11

申请号：US15710571

申请日：2017-09-20

Applicant: Medtronic, Inc.

Inventor： Steven M. Goetz ,  Richard T. Stone ,  Warren W. Ball ,  Carl D. Wahlstrand ,  Michael T. Hegland ,  Gabriela C. Molnar ,  James M. Olsen

IPC: A61N1/05 ,  A61N1/36 ,  A61N1/372

Abstract: The disclosure is directed to programming implantable stimulators to deliver stimulation energy via one or more implantable leads having complex electrode array geometries. The disclosure also contemplates guided programming to select electrode combinations and parameter values to support efficacy. The techniques may be applied to a programming interface associated with a clinician programmer, a patient programmer, or both. A user interface permits a user to view electrodes from different perspectives relative to the lead. For example, the user interface provides a side view of a lead and a cross-sectional view of the lead. The user interface may include an axial control medium to select and/or view electrodes at different axial positions along the length of a lead, and a rotational control medium to select and/or view electrodes at different angular positions around a circumference of the lead.

公开(公告)号：US09656090B2

公开(公告)日：2017-05-23

申请号：US14329583

申请日：2014-07-11

Applicant: Medtronic, Inc.

Inventor： Steven M. Goetz

IPC: A61N1/372 ,  A61N1/08 ,  A61N1/36

CPC classification number: A61N1/37252 ,  A61N1/08 ,  A61N1/36071 ,  A61N1/37247

Abstract: A programming-device user interface may include multiple levels of abstraction for programming treatment settings. A stimulation zone-programming interface may be at a highest level of abstraction and may include idealized stimulation zones. A field strength-programming interface may be at a middle level of abstraction and may include electromagnetic field-strength patterns generated by the stimulation zones, and/or electrode settings, and a depiction of how the electromagnetic fields interact with each other. An electrode-programming interface may be at a lowest level of abstraction and may depict treatment settings at an electrodes-view level. These interfaces may include a display of a stimulatable area of the patient's body. The display may include a depiction of leads and/or the underlying physiology, such as a depiction of a portion of a spine. Algorithms map treatment settings from one level of abstraction to settings at one or more other levels of abstraction.

公开(公告)号：US20160342762A1

公开(公告)日：2016-11-24

申请号：US15162099

申请日：2016-05-23

Applicant: Medtronic, Inc.

Inventor： Steven M. Goetz

IPC: G06F19/00

CPC classification number: G16H40/67 ,  A61B2560/0271 ,  A61N1/37247 ,  A61N1/37252 ,  A61N1/37264 ,  A61N1/37282 ,  G06F19/00 ,  G06F19/324 ,  G06F19/3418 ,  G06F19/3456 ,  G06F19/3481 ,  G06Q50/24 ,  G16H10/60 ,  G16H20/10 ,  G16H20/40 ,  G16H40/20 ,  G16H40/63

Abstract: The disclosure is directed to techniques for remote management of information relating to therapy delivered to a patient by an implantable medical device (IMD). A remote monitoring system for therapy programming includes an IMD that delivers therapy, e.g., neurostimulation, drug therapy, or both, to a patient, an external programming device associated with the IMD, such as a patient programmer, and a remote networking device that receives usage information from the external programming device. The external programming device communicates with the IMD via local, wireless communication, and the remote networking device receives usage information from the external programming device via a network. The usage information includes information that relates to use of therapy by the patient, use of features of the external programming device and the IMD, or use of navigation patterns of a user interface of the external programming device.

Abstract translation: 本公开涉及用于远程管理与由可植入医疗装置（IMD）递送给患者的治疗有关的信息的技术。 用于治疗编程的远程监视系统包括向患者，与IMD相关联的外部编程设备（例如患者编程器）和接收的远程联网设备（例如神经刺激，药物治疗或两者）进行治疗的IMD 来自外部编程设备的使用信息。 外部编程设备通过本地无线通信与IMD通信，并且远程网络设备经由网络从外部编程设备接收使用信息。 使用信息包括与患者使用治疗有关的信息，使用外部编程设备和IMD的特征，或使用外部编程设备的用户界面的导航模式。